Skip to main content
Retour
Watch Compare

SELECTIS HEALTH, INC.

Qualité des données : 100%
GBCS
OTC Financial Services Holding & Investment Offices
4,35 €
0,00 € (0,00%)
Cap. Boursière: 13,34 M
Prix
4,35 €
Cap. Boursière
13,34 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 17,20% annually over 5 years — strong growth
Generating 417 875,0 in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,84%
Capital efficient — spends only 0,94% of revenue on capex

Croissance

Revenue Growth (5Y)
17,20%
Au-dessus de la moyenne du secteur (5,90%)
Revenue (1Y)7,36%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-7,89%
Net Margin-1,87%
Op. Margin-3,00%

Sécurité

Debt / Equity
N/A
Current Ratio0,19
Interest Coverage-0,42

Valorisation

PE (TTM)
-16,93
En dessous de la moyenne du secteur (11,15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (2180 pairs)
Métrique Action Médiane du Secteur
P/E -16,9 11,1
P/B — 1,2
ROE % — 9,2
Net Margin % -1,9 9,4
Rev Growth 5Y % 17,2 5,9
D/E — 0,5

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Dernier 1 trimestre
Trimestre BPA Est. BPA Réel Surprise
Q12010 N/A 0,04 € —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7,36% Revenue Growth (3Y) -1,37%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 17,20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 42,17 M Net Income (TTM) -788 094,0
ROE N/A ROA -2,36%
Gross Margin N/A Operating Margin -3,00%
Net Margin -1,87% Free Cash Flow (TTM) 417 875,0
ROIC -7,89% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,19
Interest Coverage -0,42 Asset Turnover 1,26
Working Capital -16,34 M Tangible Book Value -6,73 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -16,93 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3,13%
Market Cap 13,34 M Enterprise Value 31,44 M
Per Share
EPS (Diluted TTM) -0,28 Revenue / Share 13,75
FCF / Share 0,14 OCF / Share 0,27
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,94% FCF Conversion -53,02%
SBC-Adj. FCF N/A Growth Momentum -9,84

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 39,49 M 36,78 M 40,60 M 29,29 M 20,93 M
Net Income -2,42 M -3,97 M -2,40 M -2,25 M 2,96 M
EPS (Diluted) -0,80 -1,31 -0,79 -0,82 0,11
Gross Profit — — — — —
Operating Income -2,73 M -8,96 M -286 572,0 -728 992,0 3,37 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 1,57 M 1,67 M 1,79 M 1,73 M 1,58 M
Interest Expense 2,05 M 2,17 M 2,23 M 2,50 M 2,14 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 33,45 M 40,67 M 42,49 M 46,92 M 45,93 M
Total Liabilities 38,86 M 43,64 M 41,54 M 43,82 M 42,72 M
Shareholders' Equity -5,41 M -2,96 M 952 835,0 3,10 M 3,41 M
Total Debt 19,13 M 25,18 M 34,40 M 6,31 M 39,25 M
Cash & Equivalents 680 332,0 1,48 M 1,42 M 3,94 M 3,57 M
Current Assets 3,53 M 4,96 M 4,96 M 7,97 M —
Current Liabilities 19,63 M 18,15 M 6,85 M 11,79 M —